8Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracelluar
9Luckman SP, Hughes D E, Coxon FP, et al.Nitrogen- containing bisphosphonates inhibit the mevalonate pathway and prevent post - translational prenylation of GTP - binding proteins, including Ras.J Bone Miner Res, 1998, 13(4) :581 ～ 589
10Fisher JE, Rogers MJ, Halasy JM, et al. Alendronate mechamsm of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci, 1999,96(1
1Cevik C, Otahbachi M, Nugent K, et al. Effect of 3-hy- droxy-3-methylglutaryl coenzyme A reductase inhabition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloprotei-nase-1 levels as a sign of plaque sta- bilization[J]. J Cardiovasc Med: Hagerstown, 2008, 9 (12):1 274.
2Hiro T, Kimura T, Morimoto T, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter ran- domized trial evaluated by volumetric intravascular ultra- sound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)[J]. JAm Coll Cardiol, 2009, 54(4) :293.
3Briguori C, Visconti G, Focaccio A, et al. Novel appro- aches for preventing or limiting events (Naples) 11 Trial impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J]. J Am Coil Cardi- ol, 2009,54(23):2 157.
4Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorv- astatin reload in patients on chronic statin therapy under- going percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angio plasty)Randomized Trial[J]. JAm Coll Cardiol, 2009,54(6) : 558.
5Strazzullo P, Kerry SM, Barbato A, et al. Do stains re- duce blood pressure?: a meta-analysis of randomized, controlled trials[J]. Hypertension, 2007,49(4) : 792.
6Patti G, Chello M, Candure D, et al. Randomized trial of atorvastation for reduction of postoperative atrial fibrilla- tion in patients undergoing cardiac surgery: results of the ARMYDA-3 study[J]. Circulation, 2006,114(14) : 1 455.
7Sola S, Mir WQ, Lerakis S, et al. Atorvastatin improves left ventricular systolic function and serum markers of in- flammation in nonischemic heart failure[J]. J Am Coil Cardiol, 2006,47(2) : 332.
8Ramasubbu K, Estep J, White DL, et al. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopath[J]. J Am Coil Cardiol, 2008,5(4) :415.
9Wolozin B, Wang SW, Li NC, et al. Simvastatin is asso- ciated with a reduced incidence of dementia and Parkin- son' s disease[J]. BMC Med, 2007 (5) : 20.
10Mutez E, Duhamel A, Defebvre L, et al. Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson' s disease[J]. Pharmacol Res, 2009,60 ( 1 ) : 41.
